Topic
dapagliflozin
News
19 Oct 2023
Glenmark Pharma launches triple-drug FDC for Type 2 diabetes in India
Zita DM helps improve glycemic control in adult patients with high HbA1c and/or other co-morbidities Glenmark Pharmaceuticals has launched the…
News
21 Jan 2023
MSN Group launches Sacutan tabs to treat heart disease
A bioequivalent generic, Sacutan tablets (Sacubitril/Valsartan) is indicated to reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with chronic…
News
21 Oct 2022
Glenmark launches Teneligliptin + Dapagliflozin Fixed-Dose Combination for adults with Type 2 diabetes
The company aims to improve glycemic control in adult patients with uncontrolled type‐2 diabetes Glenmark Pharmaceuticals became the first to…
News
12 Sep 2022
AstraZeneca’s Dapagliflozin reduces risk of cardiovascular death in DELIVER Phase III trial
Data extend the clinically meaningful benefits of dapagliflozin in patients with heart failure regardless of ejection fraction Detailed results from the…